Carter Van Waes - Concepedia

Author

Carter Van Waes

National Institute on Deafness and Other Communication Disorders

Also Known As

Aaron D. Tward, C Van Waes, C WAES, C. Van Waes, C. van Waes, CARTER VAN WAES, Carter Van Waes, Carter Waes, Carter van Waes, Roy Tarnuzzer

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

National Institute on Deafness and Other Communication Disorders National Institutes of Health National Cancer Institute The University of Texas MD Anderson Cancer Center University of Michigan

About

Carter Van Waes is an author at National Institute on Deafness and Other Communication Disorders specializing in medicine, tumor biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	3.3K
2	Cell Biology	9	9	1.7K
3	Immunology	7	7	961
4	Health Sciences	2	2	89
5	Engineering	1	1	1.5K

Carter Van Waes

Publications

Citations

H-Index

Page 1

	Year	Citations
Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin Katherine A. Hoadley, Christina Yau, Denise M. Wolf, Cell Tumor BiologyEngineeringTumor HeterogeneityMedicinePathology	2014	1.5K
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations Yiqun Zhang, Patrick Kwok‐Shing Ng, Melanie H. Kucherlapati, Cancer Cell Tumor BiologyCancer GenomicsPi3k/akt/mtor Pathway AlterationsTumor SuppressorSystems Biology	2017	646
Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. John B. Sunwoo, Zhong Chen, Guo‐Chung Dong, PubMed Chemoprevention StrategySquamous Cell CarcinomaImmunologyPathologyCell Death	2001	479
IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. J. Wolf, Zhong Chen, Guo‐Chung Dong, PubMed ImmunologyPathologyCancer BiologyTumor BiologyInflammation	2001	215
The A9 antigen associated with aggressive human squamous carcinoma is structurally and functionally similar to the newly defined integrin alpha 6 beta 4. Carter Van Waes, Karen Kozarsky, Annabelle Warren, PubMed Cell AdhesionIntegrin ComplexImmunologyPathologyAntigen Processing	1991	129
Epigenetic modification of <i>SOCS-1</i> differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas Jason Yeh, Carter Van Waes, Zhong Chen Molecular Cancer Therapeutics	2006	113
Endolymphatic sac tumors in von Hippel—Lindau disease Daniel Choo, Lawrence I. Shotland, Maryann Mastroianni, Journal of neurosurgery	2004	103
Autocrine and Paracrine Chemokine Receptor 7 Activation in Head and Neck Cancer: Implications for Therapy Jie Wang, Raja R. Seethala, Qing Zhang, JNCI Journal of the National Cancer Institute	2008	79
Proteomic Signatures of Epidermal Growth Factor Receptor and Survival Signal Pathways Correspond to Gefitinib Sensitivity in Head and Neck Cancer Francisco G. Pernas, Clint Allen, Mary Winters, Clinical Cancer Research	2009	63
Deficient TP53 Expression, Function, and Cisplatin Sensitivity Are Restored by Quinacrine in Head and Neck Cancer Jay Friedman, Liesl Nottingham, Praveen Duggal, Clinical Cancer Research	2007	61

Page 1